Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002940
Filing Date
2008-03-17
Accepted
2008-03-17 16:30:42
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2183743z10-k.htm 10-K 1141425
2 EXHIBIT 3.2 a2183743zex-3_2.htm EX-3.2 9328
3 EXHIBIT 10.30 a2183743zex-10_30.htm EX-10.30 51489
4 EXHIBIT 10.31 a2183743zex-10_31.htm EX-10.31 10569
5 EXHIBIT 21 a2183743zex-21.htm EX-21 7358
6 EXHIBIT 23.1 a2183743zex-23_1.htm EX-23.1 4360
7 EXHIBIT 31.1 a2183743zex-31_1.htm EX-31.1 13841
8 EXHIBIT 31.2 a2183743zex-31_2.htm EX-31.2 14001
9 EXHIBIT 32.1 a2183743zex-32_1.htm EX-32.1 13200
  Complete submission text file 0001047469-08-002940.txt   1266956
Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Filer) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28308 | Film No.: 08693273
SIC: 2834 Pharmaceutical Preparations